Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 288, Issue 4 51-4, 2005, Pages

  Bijvelds, Marcel J C ^a   Bronsveld, Inez ^b   Havinga, Rick ^c   Sinaasappel, Maarten ^b   De Jonge, Hugo R ^a   Verkade, Henkjan J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Bile flow; Cystic fibrosis transmembrane conductance regulator chloride channel; Intestinal transport; Mouse model; Pancreas

Indexed keywords

FAT; FATTY ACID; FECES LIPID; OLEIC ACID; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRIOLEIN;

ABSORPTION; ANIMAL MODEL; ARTICLE; BILE SECRETION; CYSTIC FIBROSIS; ENZYME RELEASE; EXCRETION; FATTY ACID TRANSPORT; HEPATOBILIARY SYSTEM; LIPID ABSORPTION; LIPID TRANSPORT; LIPOLYSIS; MALABSORPTION; MOUSE; NONHUMAN; PANCREAS FUNCTION; PRIORITY JOURNAL; STOMACH ACID SECRETION;

ABSORPTION; ADMINISTRATION, ORAL; ANIMALS; BILE; BILE ACIDS AND SALTS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DIETARY FATS; FATS; FATTY ACIDS, NONESTERIFIED; FECES; FEMALE; LIPOLYSIS; MALE; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUTATION; PANCREAS, EXOCRINE; TRIGLYCERIDES;

EID: 15244355053     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00295.2004     Document Type: Article

References (45)

1. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917, 1959.
2. Bronsveld I, Mekus F, Bijman J, Ballmann M, Greipel J, Hundrieser J, Halley DJ, Laabs U, Busche R, De Jonge HR, Tummler B, and Veeze HJ. Residual chloride secretion in intestinal tissue of ΔF508 homozygous twins and siblings with cystic fibrosis. The European CF Twin and Sibling Study Consortium. Gastroenterology 119: 32-40, 2000.
3. Carey MC and Duane WC. Enterohepatic circulation. In: The Liver: Biology and Pathobiology (3rd ed.), edited by Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, and Shafritz DA. New York: Raven, 1994, p. 719-767.
4. - transport in mutations associated with cystic fibrosis. Nature 410: 94-97, 2001.
5. Clarke LL, Stien X, and Walker NM. Intestinal bicarbonate secretion in cystic fibrosis mice. JOP 2: 263-267, 2001.
6. De Lisle RC, Isom KS, Ziemer D, and Cotton CU. Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse. Am J Physiol Gastrointest Liver Physiol 281: G899-G906, 2001.
7. Demarne Y, Corring T, Pihet A, and Sacquet E. Fat absorption in germ-free and conventional rats artificially deprived of bile secretion. Gut 23: 49-57, 1982.
8. Derichs N, Mekus F, Bronsveld I, Bijman J, Veeze HJ, von der Hardt H, Tummler B, and Ballmann M. Cystic fibrosis transmembrane conductance regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients. Pediatr Res 55: 69-75, 2004.
9. Doorninck JH van, French PJ, Verbeek E, Peters RH, Morreau H, Bijman J, and Scholte BJ. A mouse model for the cystic fibrosis ΔF508 mutation. EMBO J 14: 4403-4411, 1995.
10. Durie PR, Kent G, Phillips MJ, and Ackerley CA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 164: 1481-1493, 2004.
11. Eggermont E and de Boeck K. Small-intestinal abnormalities in cystic fibrosis patients. Eur J Pediatr 150: 824-828, 1991.
12. -/- mice. Proc Natl Acad Sci USA 96: 13995-14000, 1999.
13. -/- mice is associated with impairments in luminal pH and endocytosis. Gastroenterology 121: 950-957, 2001.
14. + exchange requires CFTR-mediated cell shrinkage of villus epithelium. Gastroenterology 125: 1148-1163, 2003.
15. Gray MA, Winpenny JP, Porteous DJ, Dorin JR, and Argent BE. CFTR and calcium-activated chloride currents in pancreatic duct cells of a transgenic CF mouse. Am J Physiol Cell Physiol 266: C213-C221, 1994.
16. Grossman MI and Konturek SJ. Gastric acid does drive pancreatic bicarbonate secretion. Scand J Gastroenterol 9: 299-302, 1974.
17. Grubb BR and Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79: S193-S214, 1999.
18. Heijerman HG, Lamers CB, and Bakker W. Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 114: 200-201, 1991.
19. Huggins KW, Camarota LM, Howles PN, and Hui DY. Pancreatic triglyceride lipase deficiency minimally affects dietary fat absorption but dramatically decreases dietary cholesterol absorption in mice. J Biol Chem 278: 42899-42905, 2003.
20. - exchange in rabbit, rat, and human duodenum. Gastroenterology 122: 709-724, 2002.
21. Kalek HD, Stellaard F, Kruis W, and Paumgartner G. Detection of increased bile acid excretion by determination of bile acid content in single stool samples. Clin Chim Acta 140: 85-90, 1984.
22. Kalivianakis M, Elstrodt J, Havinga R, Kuipers F, Stellaard F, Sauer PJ, Vonk RJ, and Verkade HJ. Validation in an animal model of the carbon 13-labeled mixed triglyceride breath test for the detection of intestinal fat malabsorption. J Pediatr 135: 444-450, 1999.
23. Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, Vonk RJ, and Verkade HJ. Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 69: 127-134, 1999.
24. Kaur S, Norkina O, Ziemer D, Samuelson LC, and De Lisle RC. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas. Am J Physiol Gastrointest Liver Physiol 287: G480-G490, 2004.
25. - transport in cystic fibrosis. EMBO J 21: 5662-5672, 2002.
26. Lepage G and Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 27: 114-120, 1986.
27. Mall M, Kreda SM, Mengos A, Jensen TJ, Hirtz S, Seydewitz HH, Yankaskas J, Kunzelmann K, Riordan JR, and Boucher RC. The ΔF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 126: 32-41, 2004.
28. McGowan MW, Artiss JD, Strandbergh DR, and Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29: 538-542, 1983.
29. Minich DM, Havinga R, Stellaard F, Vonk RJ, Kuipers F, and Verkade HJ. Intestinal absorption and postabsorptive metabolism of linoleic acid in rats with short-term bile duct ligation. Am J Physiol Gastrointest Liver Physiol 279: G1242-G124S, 2000.
30. Murphy GM, Billing BH, and Baron DN. A fluorimetric and enzymatic method for the estimation of serum total bile acids. J Clin Pathol 23: 594-598, 1970.
31. Ockner RK, Pittman JP, and Yager JL. Differences in the intestinal absorption of saturated and unsaturated long chain fatty acids. Gastroenterology 62: 981-992, 1972.
32. Pratha VS, Hogan DL, Martensson BA, Bernard J, Zhou R, and Isenberg JI. Identification of transport abnormalities in duodenal mucosa and duodenal enterocytes from patients with cystic fibrosis. Gastroenterology 118: 1051-1060, 2000.
33. Ratcliff R, Evans MJ, Cuthbert AW, MacVinish LJ, Foster D, Anderson JR, and Colledge WH. Production of a severe cystic fibrosis mutation in mice by gene targeting. Nat Genet 4: 35-41, 1993.
34. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, Nadeau J, Bear C, and Tsui LC. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet 12: 280-287, 1996.
35. Sbarbati A, Bertini M, Catassi C, Gagliardini R, and Osculati F. Ultrastructural lesions in the small bowel of patients with cystic fibrosis. Pediatr Res 43: 234-239, 1998.
36. - secretion. J Physiol 505: 411-423, 1997.
37. Soleimani M. Impaired pancreatic ductal bicarbonate secretion in cystic fibrosis. JOP 2: 237-242, 2001.
38. Steiner G, Poapst ME, Shumak SL, and Foster DM. Metabolism of the apolipoprotein B-containing lipoproteins. Methods Enzymol 129: 395-420, 1986.
39. Strandvik B, Einarsson K, Lindblad A, and Angelin B. Bile acid kinetics and biliary lipid composition in cystic fibrosis. J Hepatol 25: 43-48, 1996.
40. Tari A, Kuruhara Y, Yonei Y, Yamauchi R, Okahara S, Sumii K, and Kajiyama G. Effects of omeprazole and pirenzepine on enterochromaffin-like cells and parietal cells in rat stomach. J Gastroenterol 36: 375-385, 2001.
41. Voshol PJ, Minich DM, Havinga R, Oude Elferink PJ, Verkade HJ, Groen AK, and Kuipers F. Postprandial chylomicron formation and fat absorption in mice multidrug resistance gene 2 P-glycoprotein-deficient mice. Gastroenterology 118: 173-182, 2000.
42. Werner A, Bongers ME, Bijvelds MJC, de Jonge HR, and Verkade HJ. No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. J Lipid Res 45: 2277-2286, 2004.
43. + exchanger, NHE3, requires an associated regulatory protein. Proc Natl Acad Sci USA 94: 3010-3015, 1997.
44. - channel does not exacerbate the cystic fibrosis phenotype of CFTR mouse models. J Biol Chem 279: 22276-22283, 2004.
45. Zentler-Munro PL, Fine DR, Batten JC, and Northfield TC. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Gut 26: 892-901, 1985.